Plasma Androgen Receptor in Prostate Cancer

Plasma Androgen Receptor in Prostate Cancer

The therapeutic landscape of prostate cancer has expanded rapidly over the past 10 years, and there is now an even greater need to understand the biological mechanisms of resistance and to develop noninvasive biomarkers to guide treatment. The androgen receptor (AR) is known to be involved in the pa...

Full description

Bibliographic Details
Main Authors: Vincenza Conteduca, Giorgia Gurioli, Nicole Brighi, Cristian Lolli, Giuseppe Schepisi, Chiara Casadei, Salvatore Luca Burgio, Stefania Gargiulo, Giorgia Ravaglia, Lorena Rossi, Amelia Altavilla, Alberto Farolfi, Cecilia Menna, Sarah Pia Colangione, Mario Pulvirenti, Antonino Romeo, Ugo De Giorgi
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Cancers
Subjects:
androgen receptor
prostate cancer
plasma dna
biomarkers
Online Access:https://www.mdpi.com/2072-6694/11/11/1719

Internet

https://www.mdpi.com/2072-6694/11/11/1719

Similar Items